These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 21497898)
21. Use of on-site detoxification services co-located with a supervised injection facility. Gaddis A; Kennedy MC; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T J Subst Abuse Treat; 2017 Nov; 82():1-6. PubMed ID: 29021106 [TBL] [Abstract][Full Text] [Related]
22. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. Kerr T; Wood E; Small D; Palepu A; Tyndall MW CMAJ; 2003 Oct; 169(8):759-63. PubMed ID: 14557313 [TBL] [Abstract][Full Text] [Related]
23. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Wood E; Kerr T; Small W; Li K; Marsh DC; Montaner JS; Tyndall MW CMAJ; 2004 Sep; 171(7):731-4. PubMed ID: 15451834 [TBL] [Abstract][Full Text] [Related]
24. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility. Wood E; Kerr T; Stoltz J; Qui Z; Zhang R; Montaner JS; Tyndall MW Public Health; 2005 Dec; 119(12):1111-5. PubMed ID: 16214189 [TBL] [Abstract][Full Text] [Related]
25. Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis. Milloy MJ; Wood E; Reading C; Kane D; Montaner J; Kerr T Addiction; 2010 Nov; 105(11):1962-70. PubMed ID: 20825372 [TBL] [Abstract][Full Text] [Related]
26. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility. Andresen MA; Boyd N Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324 [TBL] [Abstract][Full Text] [Related]
27. Changes in injecting practices associated with the use of a medically supervised safer injection facility. Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788 [TBL] [Abstract][Full Text] [Related]
28. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Kerr T; Tyndall MW; Zhang R; Lai C; Montaner JS; Wood E Am J Public Health; 2007 Jul; 97(7):1228-30. PubMed ID: 17538061 [TBL] [Abstract][Full Text] [Related]
29. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Wood E; Tyndall MW; Zhang R; Montaner JS; Kerr T Addiction; 2007 Jun; 102(6):916-9. PubMed ID: 17523986 [TBL] [Abstract][Full Text] [Related]
31. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Harris RE; Richardson J; Frasso R; Anderson ED Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143 [TBL] [Abstract][Full Text] [Related]
32. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. Wood E; Kerr T; Spittal PM; Li K; Small W; Tyndall MW; Hogg RS; O'Shaughnessy MV; Schechter MT J Acquir Immune Defic Syndr; 2003 Jan; 32(1):2-8. PubMed ID: 12514408 [TBL] [Abstract][Full Text] [Related]
33. Opening Canada's first Health Canada-approved supervised consumption sites. Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262 [TBL] [Abstract][Full Text] [Related]
34. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA. Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842 [TBL] [Abstract][Full Text] [Related]
35. The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility. Wood E; Kerr T; Tyndall MW; Montaner JS Int J Drug Policy; 2008 Jun; 19(3):220-5. PubMed ID: 18551754 [TBL] [Abstract][Full Text] [Related]
36. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615 [TBL] [Abstract][Full Text] [Related]
37. The willingness of people who inject drugs in Boston to use a supervised injection facility. León C; Cardoso L; Mackin S; Bock B; Gaeta JM Subst Abus; 2018 Jan; 39(1):95-101. PubMed ID: 28799847 [TBL] [Abstract][Full Text] [Related]
38. Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Small W; Shoveller J; Moore D; Tyndall M; Wood E; Kerr T Qual Health Res; 2011 Jun; 21(6):743-56. PubMed ID: 21378259 [TBL] [Abstract][Full Text] [Related]
39. Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users. Reddon H; Wood E; Tyndall M; Lai C; Hogg R; Montaner J; Kerr T AIDS Educ Prev; 2011 Oct; 23(5):412-22. PubMed ID: 22010805 [TBL] [Abstract][Full Text] [Related]
40. Employment among users of a medically supervised safer injection facility. Richardson L; Wood E; Zhang R; Montaner J; Tyndall M; Kerr T Am J Drug Alcohol Abuse; 2008; 34(5):519-25. PubMed ID: 18821450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]